| Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ... Journal of Clinical Oncology 25 (15), 2035-2041, 2007 | 1078 | 2007 |
| ABT-888, an orally active poly (ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models CK Donawho, Y Luo, Y Luo, TD Penning, JL Bauch, JJ Bouska, ... Clinical cancer research 13 (9), 2728-2737, 2007 | 906 | 2007 |
| Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ... JAMA oncology 6 (5), 650-659, 2020 | 901 | 2020 |
| Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy AB Sharabi, M Lim, TL DeWeese, CG Drake The lancet oncology 16 (13), e498-e509, 2015 | 832 | 2015 |
| Prostate cancer–specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy BJ Trock, M Han, SJ Freedland, EB Humphreys, TL DeWeese, AW Partin, ... Jama 299 (23), 2760-2769, 2008 | 788 | 2008 |
| Stereotactic radiation therapy augments antigen-specific PD-1–mediated antitumor immune responses via cross-presentation of tumor antigen AB Sharabi, CJ Nirschl, CM Kochel, TR Nirschl, BJ Francica, E Velarde, ... Cancer immunology research 3 (4), 345-355, 2015 | 634 | 2015 |
| The life and death of DNA-PK SJ Collis, TL DeWeese, PA Jeggo, AR Parker Oncogene 24 (6), 949-961, 2005 | 617 | 2005 |
| A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy TL DeWeese, H van der Poel, S Li, B Mikhak, R Drew, M Goemann, ... Cancer research 61 (20), 7464-7472, 2001 | 532 | 2001 |
| The role of inflammation in the pathogenesis of prostate cancer WG Nelson, AM De Marzo, TL DeWEESE, WB Isaacs The Journal of urology 172 (5), S6-S12, 2004 | 528 | 2004 |
| Long‐term effects of androgen deprivation therapy in prostate cancer patients S Basaria, J Lieb, AM Tang, T DeWeese, M Carducci, M Eisenberger, ... Clinical endocrinology 56 (6), 779-786, 2002 | 434 | 2002 |
| Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image … N Mariados, J Sylvester, D Shah, L Karsh, R Hudes, D Beyer, S Kurtzman, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 971-977, 2015 | 383 | 2015 |
| High-resolution, small animal radiation research platform with x-ray tomographic guidance capabilities J Wong, E Armour, P Kazanzides, I Iordachita, E Tryggestad, H Deng, ... International Journal of Radiation Oncology* Biology* Physics 71 (5), 1591-1599, 2008 | 379 | 2008 |
| Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial DA Hamstra, N Mariados, J Sylvester, D Shah, L Karsh, R Hudes, D Beyer, ... International Journal of Radiation Oncology* Biology* Physics 97 (5), 976-985, 2017 | 363 | 2017 |
| DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity S Yegnasubramanian, MC Haffner, Y Zhang, B Gurel, TC Cornish, Z Wu, ... Cancer research 68 (21), 8954-8967, 2008 | 349 | 2008 |
| Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 … AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ... Jama 319 (9), 896-905, 2018 | 313 | 2018 |
| GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells X Lin, M Tascilar, WH Lee, WJ Vles, BH Lee, R Veeraswamy, K Asgari, ... The American journal of pathology 159 (5), 1815-1826, 2001 | 308 | 2001 |
| Evaluation of safety in a radiation oncology setting using failure mode and effects analysis EC Ford, R Gaudette, L Myers, B Vanderver, L Engineer, R Zellars, ... International Journal of Radiation Oncology* Biology* Physics 74 (3), 852-858, 2009 | 286 | 2009 |
| Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment AM De Marzo, TL DeWeese, EA Platz, AK Meeker, M Nakayama, ... Journal of cellular biochemistry 91 (3), 459-477, 2004 | 283 | 2004 |
| Elective nodal irradiation attenuates the combinatorial efficacy of stereotactic radiation therapy and immunotherapy AE Marciscano, A Ghasemzadeh, TR Nirschl, D Theodros, CM Kochel, ... Clinical Cancer Research 24 (20), 5058-5071, 2018 | 253 | 2018 |
| Localized prostate cancer PC Walsh, TL DeWeese, MA Eisenberger New England Journal of Medicine 357 (26), 2696-2705, 2007 | 253 | 2007 |
